-
Mashup Score: 3
Background/Purpose: While the use of oral contraceptives in females with immune mediated inflammatory diseases such as rheumatoid arthritis (RA) is acknowledged as a risk factor for venous thromboembolism (VTE), the interaction between oral contraceptive use and RA is poorly understood. In a large population based study, we aimed to estimate RA attributable VTE risk in […]
Source: acrabstracts.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 165The Relevance of a Positive ANA in New Patient Referrals to Rheumatology - ACR Meeting Abstracts - 22 day(s) ago
Background/Purpose: A positive (+)ANA titer is a common reason for Rheumatology consultation, yet the ANA is a nonspecific, non-diagnostic, lab test that is positive in up to 20% of the general population. The goal of this study is to show the low frequency of ANA associated autoimmune diseases (AD) in patients referred for a +ANA, and that low titer ANA are not helpful in diagnosing AD. Methods: This was […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
Less than 1 in 10 referrals for +ANA were associated with #autoimmune diseases ▶️7% had autoimmune diseases ▶️7% had #rheumatology diseases ▶️86% had no rheumatologic diseases #ACR24 #ACR2024 abstract 0318 👉🏽https://t.co/snxjQwLgij #antibodies #antibody https://t.co/KsN8HLIxz3
-
-
Mashup Score: 24
Background/Purpose: Weight loss is conditionally recommended for gout management; however, the magnitude of the effect of weight loss on incident gout and recurrent gout flares among overweight and obese individuals remains unknown. We aimed to examine the relation of the rate of weight loss induced by anti-obesity medications to the risk of incident gout and […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
Higher rate of #weightloss associated with lower risks of #gout & gout flares among overweight or #obese people #ACR24 #ACR2024 abstract 0268 👉🏽https://t.co/hLgv4NBvFs https://t.co/2lscjoTS5M
-
-
Mashup Score: 5Fast-tracking Axial Spondyloarthritis Diagnosis: A Novel Approach to Public Health Advocacy and Awareness - ACR Meeting Abstracts - 22 day(s) ago
Background/Purpose: The Act on Axial SpA campaign is dedicated to minimising the lengthy 8.5-year delay in diagnosing axial spondyloarthritis (axial SpA) by implementing a pioneering Gold Standard diagnosis time of just one year. Collaborating with the Belfast Health & Social Care Trust, our initiative aims to streamline the patient journey from symptom onset to diagnosis […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
Engaging those with longstanding #lowbackpain with innovative, visually compelling marketing materials with public health message effective in ✅Enhancing awareness of #Spondyloarthritis ✅Expediting time to diagnosis #ACR24 #ACR2024 abstract 0352 👉🏽https://t.co/0Qz6NjiBDI https://t.co/T4FcORpmwr
-
-
Mashup Score: 3Changes in Mortality Risk After Stopping Glucocorticosteroids – a Population-based Study in Rheumatoid Arthritis - ACR Meeting Abstracts - 23 day(s) ago
Background/Purpose: Glucocorticosteroid (GC) use is associated with increased mortality risk, especially from cardiovascular diseases (CVD) and infections, with dose and duration of use influencing risk. How long the impact lasts after stopping GC, and how this is influenced by duration of previous use, are not known. This study aims to estimate how the risk of […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
A study led by @DianeLacaille found that long-term use of glucocorticoids in rheumatoid arthritis patients increases the risk of death from heart disease and infections, with elevated risks even after stopping. #ArthritisResesearch #ACR24 🔗: https://t.co/6gXcipYXUG https://t.co/JMBdoQf1bx
-
-
Mashup Score: 46
Background/Purpose: The anti-Jo1 autoantibody (aJo1), targeting the histidyl-tRNA synthetase (HisRS) protein, is the most common diagnostic biomarker of the anti-synthetase syndrome (ASSD). So far, conflicting evidence supports the need of monitoring aJo1 levels over the disease course. The aim of this study was to analyze longitudinal levels of aJo1 in aJo1 positive patients with ASSD, […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
Anti-Jo1 autoantibody levels in anti-synthetase syndrome ➡️Associated with physician global assessment ➡️May act as prognostic indicator ➡️Higher levels close to diagnosis correlated with occurrence of ILD #ACR24 #ACR2024 abstract 2668 👉🏼https://t.co/XCG7YbfJnS #myositis https://t.co/oEH1pTqd3t
-
-
Mashup Score: 3Changes in Mortality Risk After Stopping Glucocorticosteroids – a Population-based Study in Rheumatoid Arthritis - ACR Meeting Abstracts - 23 day(s) ago
Background/Purpose: Glucocorticosteroid (GC) use is associated with increased mortality risk, especially from cardiovascular diseases (CVD) and infections, with dose and duration of use influencing risk. How long the impact lasts after stopping GC, and how this is influenced by duration of previous use, are not known. This study aims to estimate how the risk of […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
A study led by @DianeLacaille found that long-term use of glucocorticoids in rheumatoid arthritis patients increases the risk of death from heart disease and infections, with elevated risks even after stopping. #ArthritisResesearch #ACR24 🔗: https://t.co/6gXcipYXUG https://t.co/JMBdoQf1bx
-
-
Mashup Score: 51
Background/Purpose: Currently, prevention possibilities of developing ACPA-negative rheumatoid arthritis (RA) are unknown. Studying this is challenging because many ACPA-negative at-risk individuals have low risk of RA; this predominance can conceal treatment effects in prevention trials. The TREAT EARLIER-trial included participants with ACPA-negative clinically suspect arthralgia (CSA). We hypothesized that studying efficacy in ACPA-negative CSA requires […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
ACPA-negative #RheumatoidArthritis can be prevented by #methotrexate in clinically suspect arthralgia ➡️Subclinical joint inflammation, physical function & grip strength improved in ACPA-negative RA with increased-risk #ACR24 #ACR2024 abstract 2672 👉🏽https://t.co/SunQQ9FM3d https://t.co/BxEmipMJYC
-
-
Mashup Score: 16
Background/Purpose: It is standard practice to advocate for weight loss in patients with rheumatoid arthritis (RA) and obesity. Obesity and rheumatoid arthritis are both independently associated with cardiovascular disease. In addition, evidence suggests that obese RA patients are less likely to achieve remission and that weight loss may improve disease activity outcomes. Semaglutide and tirzepatide, […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
Anti-#obesity medications #Semaglutide #Tirzepatide linked with improvement in #cardiovascular disease risks & pain in #RheumatoidArthritis ✅Significant #weightloss ✅Improved acute phase reactants ✅Improved Lipids #ACR24 #ACR2024 abstract 2259 👉🏽https://t.co/jM2JVc7oHl https://t.co/uNTmeS0AJj
-
-
Mashup Score: 15Effect of Physical Activity on Mortality in Rheumatoid Arthritis: A Dose-Response Analysis - ACR Meeting Abstracts - 24 day(s) ago
Background/Purpose: Patients with Rheumatoid arthritis (RA) tend to perform less physical activity compared to the recommended guidelines. The long-term effects of physical activity on mortality and cardiorenal events are not well understood. The aim of this study was to assess the relationship between physical activity and the risk of mortality in individuals with RA, along […]
Source: acrabstracts.orgCategories: General Medicine News, RheumatologyTweet-
High #PhysicalActivity associated with lower risks of all-cause mortality in #RheumatoidArthritis ✅Should be integrated into #rheumatoid management strategies to reduce mortality risk #ACR24 #ACR2024 abstract 1885 👉🏽https://t.co/7eHe1WoLYR https://t.co/vZaSgiQHt4
-
UK study compared 16,634 female RA pts vs 65,448 controls and found all RA women at incr risk for VTE (thrombosis)[aHR=1.52) irrespective of estrogen contraceptives/HRT. Contraceptives did not increase VTE risk (aHR 2.32; 0.92, 5.85, p=0.08) #ACR24 https://t.co/AzBXI0W5dv https://t.co/Q4TaKq2ReC